CLRB going down?

NickFi Updated   
NASDAQ:CLRB   Cellectar Biosciences, Inc
CLRB has a buy rating on Zacks Rank, but it has poor financial. Based on my experience (or lack of) studying the graph, I expect the stock will drop in the future. At the moment the stock is $4.08.
The stock briefly reached $4.76 before dropping to $4.11 in a matter of minutes. In the hindsight, I wish I took the trade
I am puzzled because on tradingview the stock appears to have reached a peak of around $4.27, while on Interactive Brokers one minute chart, the peak was at $4.76. My idea for CLRB had the entry price at $4.77, which was very close to the entry price listed on IB. Maybe the transaction volume between $4.27 and $4.76 was very small.


The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.